bioAffinity Technologies, Inc. Contracts & Agreements

Form of Support Agreement (Filed With SEC on October 21, 2024)

Form of Securities Purchase Agreement, dated as of October 18, 2024, by and between the Company and the purchasers listed on the signature pages thereto (Filed With SEC on October 21, 2024)

Form of Placement Agent Warrant (Filed With SEC on October 21, 2024)

Form of Common Warrant (Filed With SEC on October 21, 2024)

Placement Agency Agreement, dated October 18, 2024, by and between bioAffinity Technologies Inc. and WallachBeth Capital LLC (Filed With SEC on October 21, 2024)

Employment Agreement between bioAffinity Technologies, Inc. and Michael Edwards, dated as of October 9, 2024 (Filed With SEC on October 10, 2024)

Consulting Agreement, dated August 21, 2024, by and between bioAffinity Technologies, Inc. and Michael Edwards (Filed With SEC on August 23, 2024)

Form of Placement Agent Warrant (Filed With SEC on August 5, 2024)

Placement Agency Agreement, dated August 2, 2024, by and between bioAffinity Technologies Inc. and WallachBeth Capital LLC (Filed With SEC on August 5, 2024)

Form of Purchase Warrant (New Warrant and Private Warrant) (Filed With SEC on August 5, 2024)

Form of Securities Purchase Agreement, dated as of August 2, 2024, by and between the Company and the investor listed on the signature page thereto (Filed With SEC on August 5, 2024)

Form of Warrant Inducement Agreement (Filed With SEC on August 5, 2024)

Form of Support Agreement (Filed With SEC on August 5, 2024)

bioAffinity Technologies, Inc. 2024 Incentive Compensation Plan (Filed With SEC on June 5, 2024)

Description of Securities (Filed With SEC on April 1, 2024)

Form of Support Agreement with schedule of signatories (Filed With SEC on March 8, 2024)

Form of Securities Purchase Agreement, dated as of March 6, 2024, by and among the Company and the investors parties thereto (Filed With SEC on March 8, 2024)

Form of Placement Agent Warrant (Filed With SEC on March 8, 2024)

Form of Warrant to Purchase Common Stock (Filed With SEC on March 8, 2024)

Placement Agency Agreement, dated March 6, 2024, by and among the Company and Wallachbeth Capital LLC (Filed With SEC on March 8, 2024)

Amendment to Michael Dougherty Offer Letter (Filed With SEC on January 31, 2024)

Bioaffinity Technologies, Inc. Management Incentive Bonus Plan (Filed With SEC on January 31, 2024)

Jamie Platt Offer Letter (Filed With SEC on December 5, 2023)

Form of Amendment to Initial Public Offering Warrants with schedule of warrant holders and warrants (Filed With SEC on September 20, 2023)

Form of Amendment to Common Share Purchase Warrants with schedule of warrant holders and warrants (Filed With SEC on September 20, 2023)

Form of Amendment to Initial Public Offering Warrants with schedule of warrant holders and warrants (Filed With SEC on September 20, 2023)

Asset Purchase Agreement, effective September 18, 2023, by and among, Precision Pathology Laboratory Services, LLC, Dr. Roby P. Joyce and Village Oaks Pathology Services, P.A (Filed With SEC on September 20, 2023)

Subscription Agreement, dated September 18, 2023, by and between The Joyce Living Trust, dated March 19, 2013, and bioAffinity Technologies, Inc (Filed With SEC on September 20, 2023)

Management Services Agreement, effective as of September 18, 2023, by and between Precision Pathology Laboratory Services, LLC and Village Oaks Pathology Services, P.A (Filed With SEC on September 20, 2023)

Succession Agreement, effective September 18, 2023, by and among, Precision Pathology Laboratory Services, LLC, Dr. Roby P. Joyce and Village Oaks Pathology Services, P.A (Filed With SEC on September 20, 2023)

Professional Services Agreement, effective as of September 18, 2023, by and between Precision Pathology Laboratory Services, LLC and Village Oaks Pathology Services, P.A (Filed With SEC on September 20, 2023)

Executive Employment Agreement, dated September 18, 2023, by and between bioAffinity Technologies, Inc. and Roby Joyce, M.D (Filed With SEC on September 20, 2023)

Assignment and Assumption of Lease Agreement, effective September 18, 2023, by and between Precision Pathology Laboratory Services, LLC and Village Oaks Pathology Services, P.A (Filed With SEC on September 20, 2023)

Office Lease, dated July 31, 2019, by and between Village Oaks Pathology Services, P.A. and 343 West Sunset, LLC (Filed With SEC on September 20, 2023)

Assignment and Assumption Agreement, effective September 18, 2023, by and between Precision Pathology Laboratory Services, LLC and Village Oaks Pathology Services, P.A (Filed With SEC on September 20, 2023)

Equipment Usage Attachment, dated effective as of August 9, 2019, by and between Gen-Probe Sales & Service, Inc., together with its subsidiaries and affiliates and Village Oaks... (Filed With SEC on September 20, 2023)

Master Agreement, dated as of January 29, 2015, by and between Leica Microsystems, Inc. and Precision Pathology, as amended by Amendment No. 1 to the Master Agreement, dated on or... (Filed With SEC on September 20, 2023)

Strategic Relationship License Agreement, dated December 1, 2022, by and between Pathology Watch, Inc. and Precision Pathology Services (Filed With SEC on September 20, 2023)

Bill of Sale signed by Village Oaks Pathology Services, P.A., effective as of September 18, 2023 (Filed With SEC on September 20, 2023)

Form of Underwriting Agreement (Filed With SEC on September 20, 2023)

Form of Common Stock Purchase Warrant to be issued as part of the Units to be sold in the Offering (Filed With SEC on September 20, 2023)

Form of Warrant Agent Agreement for the Warrants to be issued as part of the Units to be sold in the Offering (Filed With SEC on September 20, 2023)

Form of Representatives Warrant issued to WallachBeth Capital, LLC in connection with the Units sold in the Offering (Filed With SEC on September 20, 2023)

Form of Amendment to Common Share Purchase Warrants with schedule of warrant holders and warrants (Filed With SEC on September 20, 2023)

Amendment, effective as of August 1, 2023, to Employment Agreement, dated February 1, 2015, by and between bioAffinity Technologies, Inc. and Maria Zannes (Filed With SEC on July 28, 2023)

bioAffinity Technologies, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on June 7, 2023)

Offer Letter between bioAffinity Technologies, Inc. and Michael Dougherty dated April 11, 2023 (Filed With SEC on May 1, 2023)

Warrant Agent Agreement, dated September 6, 2022, by and between the Company and VStock Transfer, LLC for the Warrants issued as part of the Units sold in the Offering pursuant to... (Filed With SEC on September 6, 2022)

Form of Non-tradeable Common Stock Purchase Warrant, issued as part of the Units sold in the Offering pursuant to the Underwriting Agreement (Filed With SEC on September 6, 2022)

Form of Tradeable Common Stock Purchase Warrant, issued as part of the Units sold in the Offering pursuant to the Underwriting Agreement (Filed With SEC on September 6, 2022)

Underwriting Agreement, dated August 31, 2022, by and between the Company and WallachBeth Capital, LLC (Filed With SEC on September 6, 2022)

Form of (Non-tradeable) Common Stock Purchase Warrant to be issued as part of the Units to be sold in the Offering pursuant to the Underwriting Agreement (Filed With SEC on August 18, 2022)

Form of Warrant Agent Agreement for the Warrants to be issued as part of the Units to be sold in the Offering (Filed With SEC on August 18, 2022)

Form of (Tradeable) Common Stock Purchase Warrant to be issued as part of the Units to be sold in the Offering pursuant to the Underwriting Agreement (Filed With SEC on August 18, 2022)

Form of Underwriting Agreement (Filed With SEC on August 18, 2022)

Form of Underwriting Agreement (Filed With SEC on August 5, 2022)

Form of Placement Agents Warrant to be issued to WallachBeth Capital, LLC (Filed With SEC on August 5, 2022)

Form of Warrant Agent Agreement for the Warrants to be issued as part of the Units to be sold in the Offering (Filed With SEC on August 5, 2022)

Form of (Non-tradeable) Common Stock Purchase Warrant to be issued as part of the Units to be sold in the Offering pursuant to the Underwriting Agreement (Filed With SEC on July 28, 2022)

Form of Note Extension Common Stock Purchase Warrant issued to holders of the Registrants Convertible Promissory Notes as consideration to extend the maturity date to October 31,... (Filed With SEC on July 28, 2022)

Form of Amendment to Convertible Promissory Note of the Registrant to extend the maturity date to October 31, 2022 (Filed With SEC on July 28, 2022)

Form of Amendment to Unsecured Convertible Promissory Note of the Registrant to extend the maturity date to October 31, 2022 (Filed With SEC on July 28, 2022)

Secured Convertible Note Purchase Agreement dated December 21, 2018, as amended to date (Filed With SEC on July 28, 2022)

Form of Warrant Agent Agreement for the Warrants to be issued as part of the Units to be sold in the Offering (Filed With SEC on July 28, 2022)

Form of (Tradeable) Common Stock Purchase Warrant to be issued as part of the Units to be sold in the Offering pursuant to the Underwriting Agreement (Filed With SEC on July 28, 2022)

Form of Representatives Warrant to be issued to WallachBeth Capital, LLC pursuant to the Underwriting Agreement (Filed With SEC on July 28, 2022)

Form of Placement Agents Warrant to be issued to WallachBeth Capital, LLC (Filed With SEC on July 28, 2022)

Form of Underwriting Agreement (Filed With SEC on July 28, 2022)

Form of Warrant Agent Agreement for the Warrants to be issued as part of the Units to be sold in the Offering (Filed With SEC on June 16, 2022)

Form of Underwriting Agreement (Filed With SEC on June 16, 2022)

Form of Registrants Common Stock Certificate (Filed With SEC on June 16, 2022)

Form of Common Stock Purchase Warrant to be issued as part of the Units to be sold in the Offering pursuant to the Underwriting Agreement (Filed With SEC on June 16, 2022)

Executive Chairman Employment Agreement dated January 1, 2020, by and between Registrant and Steven Girgenti, as amended (Filed With SEC on May 25, 2022)

Common Stock Purchase Warrant Issued to San Antonio Economic Development Corporation dated March 17, 2017 (Filed With SEC on May 25, 2022)

Form of Common Stock Purchase Warrant Agreement Issued to Holders of the Registrants Convertible Promissory Notes (Filed With SEC on May 25, 2022)

Form of Placement Agent Warrant to be issued to WallachBeth Capital, LLC (Filed With SEC on May 25, 2022)

Form of Representatives Warrant to be issued to WallachBeth Capital, LLC pursuant to the Underwriting Agreement (Filed With SEC on May 25, 2022)

Form of Common Stock Purchase Warrant to be issued as part of the Units to be sold in the Offering pursuant to the Underwriting Agreement (Filed With SEC on May 25, 2022)

Secured Convertible Note Purchase Agreement dated December 21, 2018, as amended to date (Filed With SEC on May 25, 2022)

Form of Secured Convertible Promissory Note of Registrant used in private offerings from December 2018 to July 2020 (Filed With SEC on May 25, 2022)

Form of Unsecured Convertible Promissory Note of the Registrant used in private offerings from October 2020 to August 2021 (Filed With SEC on May 25, 2022)

Form of Convertible Promissory Note of the Registrant used in private offerings from October 2021 to January 2022 (Filed With SEC on May 25, 2022)

2014 Equity Incentive Plan of Registrant, as amended (Filed With SEC on May 25, 2022)

Employment Agreement dated February 1, 2015, by and between Registrant and Maria Zannes (Filed With SEC on May 25, 2022)

Employment Agreement dated April 4, 2016, by and between Registrant and Vivienne Rebel, as amended (Filed With SEC on May 25, 2022)

Employment Agreement dated February 1, 2015, by and between Registrant and Timothy Zannes (Filed With SEC on May 25, 2022)

Consulting Agreement dated May 25, 2017, by and between Registrant and Michael Edwards, as amended (Filed With SEC on May 25, 2022)

License Agreement to Participate in the UTSA New Venture Incubator Program dated June 15, 2015, by and between Registrant and the University of Texas at San Antonio (Filed With SEC on May 25, 2022)

Joint Development Agreement dated October 1, 2018, by and between the Registrant and Village Oaks Pathology Services, P.A. d/b/a Precision Pathology Services (Filed With SEC on May 25, 2022)

Agreement dated October 17, 2020, by and between Registrant and GO2 Partners (Filed With SEC on May 25, 2022)

Form of Note Purchase Agreement used by the Registrant in its private offering of Convertible Promissory Notes issued between October 2021 and January 2022 (Filed With SEC on May 25, 2022)

Form of Underwriting Agreement (Filed With SEC on May 25, 2022)

Category

Industry

Companies

Contracts

bioAffinity Technologies, Inc. Contracts & Agreements